Where does UNIVERSITÄTSKLINIKUM Regensburg rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), UNIVERSITÄTSKLINIKUM Regensburg ranks #30,518 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does UNIVERSITÄTSKLINIKUM Regensburg hold?

UNIVERSITÄTSKLINIKUM Regensburg holds 9 US utility patents granted between 2017 and 2025, spanning 9 technology areas.

What is UNIVERSITÄTSKLINIKUM Regensburg's Innovation Score?

UNIVERSITÄTSKLINIKUM Regensburg has an Innovation Score of 26.9 out of 100 (22nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does UNIVERSITÄTSKLINIKUM Regensburg focus on?

UNIVERSITÄTSKLINIKUM Regensburg's top technology area is C07K (Peptides) with 7 patents. Grants appear in 9 CPC subclasses total.

Is UNIVERSITÄTSKLINIKUM Regensburg's patent grant rate increasing or decreasing?

UNIVERSITÄTSKLINIKUM Regensburg's recent grant velocity is +33% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for UNIVERSITÄTSKLINIKUM Regensburg's patents?

UNIVERSITÄTSKLINIKUM Regensburg's patents average 10.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the UNIVERSITÄTSKLINIKUM Regensburg patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

UNIVERSITÄTSKLINIKUM Regensburg

USPTO PatentsView assignee record - 9 granted patents across 9 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Universitätsklinikum ranks #30,518 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 9 technology areas.

#30,518
of 49,997 US assignees by volume: 22nd percentile
by Innovation Score (26.9/100): 10.1
avg claims per patent: +33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R30518 · Foreign Corporation #30,518 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #30,518/49,997
PHOTO-FINISH Universite Libanaise
CPC-NARROW C07K · 9 areas
INNOV-THIN 26.9/100
CLAIMS-PAR 10.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Universite Libanaise (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
UNIVERSITÄTSKLINIKUM… · this assignee

27
3D Lighting… · lowest

7

What this shows Universitätsklinikum's Innovation Score is 26.9/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Universitätsklinikum's grants concentrate

UNIVERSITÄTSKLINIKUM Regensburg is a focused PatentsView assignee: 9 CPC subclasses with 77.8% of grants classified under C07K (Peptides). Peak complete grant year is 2017 (2 grants) versus a trough of 1 in 2018. By volume, Universitätsklinikum sits between Universite Libanaise and UZ Technology (Shenzhen) Company Limited.

Universitätsklinikum's three-year grant acceleration

UNIVERSITÄTSKLINIKUM Regensburg shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Universite Libana…

9
University OF Cyp…

9
University OF Ess…

9
University OF Pit…

9
USA Industries

9
USM Holding

9
Utility Solutions

9
UZ Technology (Sh…

9
UniversitÄTsklini… ◀

9

What this shows UNIVERSITÄTSKLINIKUM holds 9 patents at rank #30,474, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near UNIVERSITÄTSKLINIKUM

By rank, the assignees closest to #30,474 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in UNIVERSITÄTSKLINIKUM's primary technology class.

Universitätsklinikum's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 22nd percentile higher than 22% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

UNIVERSITÄTSKLINIKUM Regensburg patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	22.2%
2018	1	11.1%
2020	1	11.1%
2021	2	22.2%
2024	1	11.1%
2025partial year	2	22.2%

Which technologies does UNIVERSITÄTSKLINIKUM Regensburg patent most?

C07K - Peptides 7

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 2

C07C - Acyclic OR Carbocyclic Compounds 2

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#30,518

of 49,997 tracked assignees

Innovation Score

26.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

UNIVERSITÄTSKLINIKUM Regensburg's patent record in context - here's where to go next.

UNIVERSITÄTSKLINIKUM Regensburg's lead technology class is C07K (Peptides), 77.8% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #30,518 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare UNIVERSITÄTSKLINIKUM Regensburg against Universite Libanaise, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.